Back to results
US 2001/0036638 A1Published application
Combinatorial enzymatic complexes
AssigneeRigel Pharmaceuticals, Inc.
InventorsGarry P. Nolan, Donald Payan
Life of this patent
Estimating the term…
Abstract
The invention relates to the formation of novel in vivo combinatorial enzyme complexes for use in screening candidate drug agents for bioactivity.
Claims26
A cell containing a composition comprising:
- a) an exogeneous scaffold comprising at least a first binding site and a second binding site;
- and
- b) at least a first and a second enzyme, wherein at least one of said enzymes is heterologous to said cell;
- wherein said first enzyme is bound to said first binding site and said second enzyme is bound to said second binding site.
1 more element
A cell containing a composition comprising:
- a) nucleic acid encoding an exogeneous scaffold comprising at least a first binding site and a second binding site;
- and
- b) nucleic acid encoding at least a first and a second enzyme, wherein at least one of said enzymes is heterologous to said cell;
- wherein said first enzyme is capable of being bound to said first binding site and said second enzyme is capable of being bound to said second binding site.
1 more element
A method of screening for a bioactive agent, said method comprising:
- a) expressing in a plurality of host cells nucleic acid encoding an exogeneous scaffold comprising at least a first binding site and a second binding site;
- b) expressing in said plurality of host cells nucleic acids encoding at least a first enzyme and a second enzyme;
- under conditions where said nucleic acids are expressed, and said first enzyme binds to said first binding site and said second enzyme binds to said second binding site;
- c) screening said host cells for a cell exhibiting an altered phenotype, wherein said altered phenotype is due to the presence of a bioactive agent.
1 more element
A method of screening for a bioactive agent, said method comprising:
- a) expressing in a plurality of host cells a library of nucleic acids encoding a library of scaffolds, each scaffold comprising at least a first binding site and a second binding site;
- b) expressing in said cells a library of nucleic acids encoding a library of enzymes;
- under conditions where said nucleic acids are expressed, and at least some of said enzymes bind to said scaffolds;
- c) screening said host cells for an altered phenotype.
1 more element
A composition comprising:
- a) a scaffold comprising at least a first and a second binding site;
- and
- b) at least a first and a second enzyme;
- wherein said first enzyme is bound to said first binding site and said second enzyme is bound to said second binding site, wherein said enzymes do not biologically react with said scaffold or each other.
1 more element
A method comprising:
- a) providing a scaffold comprising at least a first binding site and a second binding site;
- b) providing at least a first and a second enzyme, wherein said first enzyme is bound to said first binding site and said second enzyme is bound to said second binding site to form a enzyme complex;
- c) providing said enzyme complex with at least one precursor, under conditions wherein said precursor is enzymatically altered by at least one of said enzymes to form a bioactive agent.
Dependencies are inferred from the claim text.